Stage-specific expression of protease genes in the apicomplexan parasite, Eimeria tenella. by Katrib, M et al.
Katrib et al. BMC Genomics 2012, 13:685
http://www.biomedcentral.com/1471-2164/13/685RESEARCH ARTICLE Open AccessStage-specific expression of protease genes in the
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Background: Proteases regulate pathogenesis in apicomplexan parasites but investigations of proteases have been
largely confined to the asexual stages of Plasmodium falciparum and Toxoplasma gondii. Thus, little is known about
proteases in other Apicomplexa, particularly in the sexual stages. We screened the Eimeria tenella genome database
for proteases, classified these into families and determined their stage specific expression.
Results: Over forty protease genes were identified in the E. tenella genome. These were distributed across aspartic
(three genes), cysteine (sixteen), metallo (fourteen) and serine (twelve) proteases. Expression of at least fifteen
protease genes was upregulated in merozoites including homologs of genes known to be important in host cell
invasion, remodelling and egress in P. falciparum and/or T. gondii. Thirteen protease genes were specifically
expressed or upregulated in gametocytes; five of these were in two families of serine proteases (S1 and S8) that are
over-represented in the coccidian parasites, E. tenella and T. gondii, distinctive within the Apicomplexa because of
their hard-walled oocysts. Serine protease inhibitors prevented processing of EtGAM56, a protein from E. tenella
gametocytes that gives rise to tyrosine-rich peptides that are incorporated into the oocyst wall.
Conclusion: Eimeria tenella possesses a large number of protease genes. Expression of many of these genes is
upregulated in asexual stages. However, expression of almost one-third of protease genes is upregulated in,
or confined to gametocytes; some of these appear to be unique to the Coccidia and may play key roles in the
formation of the oocyst wall, a defining feature of this group of parasites.
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Proteases are essential regulators of pathogenesis in the
Apicomplexa, a phylum that includes obligate, intracel-
lular protozoan parasites of great human health
(e.g., Plasmodium species, causing malaria, Toxoplasma
gondii, causing toxoplasmosis, and Cryptosporidium,
causing cryptosporidiosis) and agricultural and economic
significance (e.g., Neospora caninum, the cause of foetal
abortion in cattle, and Eimeria species, the causative
agents of coccidiosis in poultry, cattle, sheep and
rabbits). Extensive study of Plasmodium species and T.
gondii has established that proteases help to coordinate
and regulate the lifecycles of these parasites, playing key* Correspondence: nicholas.smith@jcu.edu.au
2Queensland Tropical Health Alliance Research Laboratory, Faculty of
Medicine, Health and Molecular Sciences, James Cook University, Cairns
Campus, McGregor Road, Smithfield, QLD 4878, Australia
Full list of author information is available at the end of the article
© 2012 Katrib et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the orroles in host cell invasion, general catabolism, host cell
remodelling and egress from host cells [1]. These
processes are all associated with the asexual stages of
apicomplexan parasites. By contrast, relatively little is
known about what roles proteases may play in the sexual
phase of the apicomplexan lifecycle though it is known
that a subtilisin 2 is detected specifically in the gametocyte
proteome [2] and expression of falcipain 1 is upregulated
in gametocytes [3] of P. falciparum. Moreover, it has been
demonstrated that the cysteine protease inhibitor, E64d,
or the targeted genetic disruption of falcipain 1 can inhibit
oocyst production in P. falciparum [3,4]. Likewise, the
proteosome inhibitors, epoxomicin and thiostrepin, ex-
hibit gametocytocidal activity [5,6].
In comparison to P. falciparum and T. gondii, pro-
teases from Eimeria species have been studied far less
intensively, despite the economic importance of this
genus of parasites. Thus, homologs or orthologs oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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or T. gondii have also been identified in Eimeria species
including an aspartyl protease [7-10], an aminopeptidase
[11], a rhomboid protease [12,13], a subtilisin 2-like pro-
tease [10,13,14], three cathepsin Cs [15], a cathepsin L
[15] and an orthologue of toxopain, a cathepsin B cyst-
eine protease [14,15]. As for P. falciparum and T. gondii,
these proteases have been found in the asexual stages of
Eimeria and are mostly predicted to play roles in host
cell invasion, though expression of some of these
enzymes is associated with the sporulation of the devel-
oping oocyst [11,13,15]. However, it is hypothesized that
proteolytic processing of two proteins from the wall
forming bodies of the macrogametocytes of Eimeria –
GAM56 and GAM82 – is essential for the subsequent
incorporation of tyrosine-rich peptides into the oocyst
wall [16].
In this study, we screened the E. tenella genomic data-
base for genes encoding proteases, classified these into
clans and families and designed PCR probes for them.
Using cDNA produced from E. tenella stage specific
mRNA, we carried out semi-quantitative PCR to deter-
mine the stage specificity of expression of the protease
genes, especially to identify protease mRNAs that were
upregulated in gametocytes. In order to further resolve
which of these may be involved in oocyst wall formation,
we carried out a processing assay using gametocyte
extracts of E. tenella, whereby a variety of specific prote-
ase inhibitors were tested for their ability to inhibit the
processing of GAM56 into smaller, putative oocyst wall
proteins.
Results
Identification of potential protease genes in Eimeria tenella
The genome of E. tenella (Houghton strain) was
sequenced by the Parasite Genomics Group at the Well-
come Trust Sanger Institute and provided pre-
publication for the current analysis. The Parasite Gen-
omics Group plan to publish the annotated sequence in
a peer-reviewed journal in the coming future. The E.
tenella genome database (http://www.genedb.org/Home-
page/Etenella) was explored to identify genes that were
automatically predicted to code for aspartic, cysteine,
metallo and serine proteases. Database mining revealed
over 60 gene sequences whose predicted open reading
frames were associated with potential peptidase activity.
Manual annotation of the genes was performed by
BLAST search of apicomplexan genome databases to
identify phylogenetically closely related nucleotide
sequences and by BLAST search of various protein data-
bases to identify the most closely related, experimentally
characterized homologs available (Table 1). Additionally,
the predicted proteins were analysed for conserved
motifs and domains to further validate protein function(Table 1). Each predicted protein was then assigned a
five-tiered level of confidence for function using an
Evidence Rating (ER) system (Table 1). The evidence rat-
ing system, described previously [17], allocates genes an
overall score (ER1-5), indicating how compelling the
bioinformatic and experimental evidence is for protein
function. An ER1 rating signifies extremely reliable
experimental data to support protein function in the
particular species being investigated, in this case
Eimeria, whereas ER5 indicates no experimental or bio-
informatic evidence for gene function. Genes with an
ER5 were eliminated from further investigation. After
this validation process was performed, 45 putative prote-
ase genes remained and these could be classified into
clans and families of aspartic, cysteine, metallo and
serine proteases (Table 1), including: three aspartic pro-
teases, all within family A1 in clan AA; 16 cysteine pro-
teases, the vast majority (15) of which were in clan CA,
five being cathepsins (family C1), one calpain (family
C2), eight ubiquitinyl hydrolases (family C19) and one
OTU protease (family C88), as well as a single clan CF
pyroglutamyl peptidase (family C15); 14 metallo pro-
teases, distributed over five clans (MA (6), ME (5), MF
(1), MK (1) and MM (1)) and seven families (M1 (2),
M41 (3), M48 (1), M16 (5), M17 (1), M22 (1) and M50
(1)); and 12 serine proteases in clan PA (three trypsin-
like proteases in family S1), clan SB (six subtilisin-like
proteases in family S8), clan SC (one prolyl endopeptid-
ase in family S33), clan SK (one Clp protease in family
S14) and clan ST (a rhomboid protease – rhomboid
protease 1 – in family S54). Three additional rhomboid
proteases were identified in the E. tenella genome data-
base by using BLASTP to search the database using, as
queries, homologs described in T. gondii: rhomboid
protease 3 (ETH_00032220, Supercontig_69: 140161–
141340; 4.0e52); rhomboid protease 4 (ETH_00009820,
Supercontig_44: 17996–24858; 9.8e-164); and rhomboid
protease 5 (ETH_00040480, contig NODE_916_
length_3953_cov_17.775614: 53–3466; 7.2e-65). How-
ever, we were unable to confirm coding sequences or
stage-specific expression for any of these three genes.
Stage-specific protease gene expression
To assess the stage specific gene expression of putative
proteases identified in the E. tenella database, different
stages of the parasite lifecycle were isolated and total
RNA purified. These stages included merozoites, 134 h
gametocytes, unsporulated oocysts, sporulated oocysts
as well as uninfected caeca control tissue. RT-PCR was
performed and the stage-specific cDNA samples were
subjected to control PCRs to determine purity (Figure 1).
Purification of merozoite and gametocyte lifecycle stages
inevitably results in co-purification of host tissue, hence,
the E. tenella β-actin structural gene was amplified to
Table 1 Protease genes identified in the Eimeria tenella genome database
Protease/Gene Identifier/Contig Clan Family BLAST Apicomplexa
(Database: nucleotide)
BLAST NCBI (Database:
PDB, Swissprot, NR)
Family
Domains (Pfam,
MEROPS,
InterProScan)
Evidence
Rating
Aspartic Proteases
Eimepsin 1 ETH_00001725 on
Supercontig_54
AA A1 Theileria annulata strain Ankara
genomic DNA chromosome 3
(E=2e-17)
PDB: Porcine Pepsin
(E=4e-11)
partial ER1
Eimepsin 2 ETH_00007420 on
Supercontig_38
AA A1 Toxoplasma gondii ME49
gcontig_1112359860822
(E=7e-36)
NR: aspartic protease 7
[Toxoplasma gondii]
(E=3e-37)
none ER3/4
Eimepsin 3 ETH_00008525 on
Supercontig_8
AA A1 Plasmodium berghei whole
genome shotgun assembly,
contig PB_RP2841 (E=1e-93)
PDB: Human pepsin
(E=7e-56)
complete ER2
Cysteine Proteases
Cathepsin B ETH_00003570 on
Supercontig_23
CA C1 Toxoplasma gondii GAB2-2007-
GAL-DOM2 contig00350
(E= 1e-12)
PDB: Human Recombinant
Procathepsin B (E=2e-58)
Complete ER2
Cathepsin L ETH_00033530 on
NODE_2923_length_1315_cov_12.253232
CA C1 Toxoplasma gondii ME49
gcontig_1112359872114
(E= 9e-43)
PDB: Toxoplasma gondii
Cathepsin L (Tgcpl)
(E=1e-64)
Complete ER2
Cathepsin C1 ETH_00019750 on
Supercontig_2
CA C1 Toxoplasma gondii ME49
gcontig_1112359873648
(E= 5e-46)
PDB: Porcine Cathepsin H
(E=3e-11)
Partial ER2/3
Cathepsin C2 ETH_0005000 on
NODE_22022_length_2554_cov_8.124119
CA C1 Toxoplasma gondii GT1
gcontig_1107000835548
(E=2e-11)
PDB: Human Dipeptidyl
Peptidase I (Cathepsin C)
(E=0.016)
Partial ER3/4
Cathepsin C3 ETH_00001590,
ETH_00001595 and ETH_00001600 on
Supercontig_115
CA C1 Cryptosporidium hominis strain
TU502 chromosome 4
CHRO014106 (E=1e-34)
PDB: Cathepsin C Rattus
norvegicus (E= 3e-13)
partial ER2
Calpain ETH_00004075 on
Supercontig_49
CA C2 Toxoplasma gondii ME49
gcontig_1112359873650
(E=5e-96)
PDB: Human Calpain 8
(E= 1e-16)
Complete ER2
Ubiquitinyl hydrolase 1 ETH_00012075
on Supercontig_122
CA C19 Cryptosporidium muris RN66
gcontig_1106632353963
(E=2e-87)
Swiss-Prot: ubiquitin
specific peptidase 39 [Mus
musculus] (E=1e-116)
Complete ER2
Ubiquitinyl hydrolase 2 ETH_00034675
on Supercontig_3
CA C19 Cryptosporidium muris RN66
gcontig_1106632353937
(E=3e-35)
Swiss-Prot: ubiquitin
specific peptidase 5
(isopeptidase T)[Mus
musculus] (E=7e-81)
Partial ER2
Ubiquitinyl hydrolase 3 ETH_00001555
on Supercontig_115
CA C19 Neospora caninum Liverpool
ubiquitin carboxyl-terminal
hydrolase, related
(NCLIV_041690) mRNA, partial
cds (E=63e-94)
PDB: Ubp-Family
Deubiquitinating Enzyme
[human] (E= 5e-40)
Complete ER2
Ubiquitinyl hydrolase 4 ETH_00007310
on Supercontig_39
CA C19 Cryptosporidium muris RN66
gcontig_1106632353835
(E=1e-60)
PDB: Usp14, A
Proteasome-Associated
Deubiquitinating Enzyme
(E= 5e-40)
Complete
(disrupted)
ER2
Ubiquitinyl hydrolase 5 ETH_00003260
on Supercontig_106
CA C19 Plasmodium falciparum VS/1
cont1.2577 (E=2e-49)
PDB: Human Ubiquitin
Carboxyl-Terminal
Hydrolase 8 (E=2e-37)
Partial ER2
Ubiquitinyl hydrolase 6 ETH_00020635
on Supercontig_5
CA C19 Toxoplasma gondii GT1
gcontig_1107000919460
(E=1e-12)
Swiss-Prot: Ubiquitin
carboxyl-terminal
hydrolase 26 Arabidopsis
thaliana
(E= 2e-12)
Partial ER2/3
Ubiquitinyl hydrolase 7 ETH_00008925
on Supercontig_8
CA C19 Plasmodium vivax SaI-1
ctg_6569 (E=1e-30)
PDB: Ubiquitin-Usp2
Complex [human]
(E= 2e-15)
Partial ER2
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Table 1 Protease genes identified in the Eimeria tenella genome database (Continued)
Ubiquitinyl hydrolase 8 ETH_00003260
on Supercontig_106
CA C19 Neospora caninum Liverpool
Ubiquitin carboxyl-terminal
hydrolase, related
(NCLIV_024510) mRNA,
complete cds (E=8e-17)
PDB: Covalent Ubiquitin-
Usp2 Complex [human]
(E= 4e-10)
Partial ER2/3
OTU protease no gene name on
NODE_10106_length_3351_cov_7.612056
CA C88 Toxoplasma gondii ME49
gcontig_1112359861240
(E=3e-9)
PDB: OTU [Saccharomyces
cerevisiae] (E= 2e-11)
None ER3/4
Pyroglutamyl peptidase ETH_00030160
on Supercontig_14
CF C15 Toxoplasma gondii ME49
gcontig_1112359873116
(E=0.1)
Swiss-Prot: Pyrrolidone
Carboxyl Peptidase
(pyroglutamyl peptidase)
Chromobacterium
violaceum (E= 8e-5)
Partial ER3
Metallo Proteases
Aminopeptidase N 1 ETH_00013105 on
Supercontig_9
MA M1 Neospora caninum Liverpool
complete genome,
chromosome X (E=1e-24)
PDB: Aminopeptidase N
From Human Pathogen
Neisseria meningitidis
(E=1e-144)
Partial ER2
Aminopeptidase N 2 ETH_00015595 on
Supercontig_153
MA M1 Babesia bovis strain T2Bo
chromosome 4
gcontig_1104837696308
(E=7e-57)
PDB: M1
Alanylaminopeptidase
From Malaria (E= 4e-65)
Partial ER2
ATP-dependant Zn protease 1 no gene
name on
NODE_975_length_1397_cov_15.574087
MA M41 Plasmodium falciparum FCC-2/
Hainan cont1.4384 (E=9e-31)
PDB: Ftsh Protease
Domain [Aquifex aeolicus]
(E=1e-21)
Complete ER2
ATP-dependant Zn protease 2
ETH_00018435 on Supercontig_60
MA M41 Plasmodium falciparum VS/1
cont1.4464 (E=2e-68)
PDB: Ftsh [Escherichia coli]
(E=1e-65)
Complete ER2
ATP-dependant Zn protease 3
ETH_00010985 on Supercontig_4
MA M41 Toxoplasma gondii ME49
gcontig_1112359860098
(E=2e-54)
PDB: Human Paraplegin
(FtsH endopeptidase
family) (E=7e-40)
Partial ER3
CaaX prenyl protease ETH_00017305 on
Supercontig_76
MA M48 Babesia bovis strain T2Bo
chromosome 4
gcontig_1104837696380
(E=2e-77)
Swiss-Prot: CAAX prenyl
protease 1 homolog
[Arabidopsis thaliana]
(E=2e-83)
Complete ER2
Insulysin 1 ETH_00011835 on
Supercontig_36
ME M16 Plasmodium vivax SaI-1
ctg_7222 (E=5e-168)
PDB: Bovine Bc1 (Zn-
dependant insulinase)
(E=1e-101)
Complete ER2
Insulysin 2 ETH_00032950 on
Supercontig_103
ME M16 Babesia bovis T2Bo
chromosome 3 (E=1e-133)
PDB: Yeast Mitochondrial
Processing Peptidase
(E=4e-60)
Complete ER2
Insulysin 3 ETH_00001730 on
Supercontig_54
ME M16 Toxoplasma gondii ME49
gcontig_1112359871056
(E=3e-90)
PDB: Human insulin
degrading enzyme (Ide)
(E=2e-46)
Complete ER1/2
Insulysin 4 no gene name on
Supercontig_901
ME M16 Toxoplasma gondii VEG
gcontig_1104442817478
(E=1e-22)
PDB: Human insulin
degrading enzyme (Ide)
(E=3e-17)
Partial ER2/3
Insulysin 5 no gene name on
NODE_2627_length_1769_cov_14.530243
ME M16 - PDB: Pitrilysin (M16 family)
[Escherichia coli O157:H7]
(E=7e-05)
None ER4
Leucine aminopeptidase ETH_00012380
on Supercontig_27
MF M17 Toxoplasma gondii ME49
cytosol aminopeptidase,
mRNA
(E=4e-54)
PDB: E. coli
Aminopeptidase A (Pepa)
(E=1e-53)
Complete ER2
O-sialoglycoprotease ETH_00020530 on
Supercontig_5
MK M22 Toxoplasma gondii ME49
glycoprotease family domain-
containing protein, mRNA
(E=1e-47)
PDB: Methanococcus
jannaschii Kae1-Bud32
Fusion Protein (Kae1:
sialoglycoprotease
homologue) (E=1e-51)
Complete
(disrupted)
ER2
S2P-like protease ETH_00009130 on
Supercontig_80
MM M50 - NR: peptidase, M50 family
protein [Toxoplasma
gondii] (E=4e-21)
Complete ER3
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Table 1 Protease genes identified in the Eimeria tenella genome database (Continued)
Serine Proteases
Trypsin 1 ETH_00028355 on
Supercontig_45
PA S1 Babesia bovis strain T2Bo
chromosome 4
gcontig_1104837696308
(E=1e-56)
Swiss-Prot: Protease Do-
like 10 [Arabidopsis
thaliana] (E=2e-63)
Complete ER2
Trypsin 2 ETH_00012215 on
Supercontig_27
PA S1 Neospora caninum Liverpool
complete genome,
chromosome IX (E=1e-21)
Swiss-Prot: Protease Do-
like 9 [Arabidopsis thaliana]
(E=1e-63)
Complete ER2/3
Trypsin 3 ETH_00015245 on
Supercontig_30
PA S1 Toxoplasma gondii ME49
gcontig_1112359861240
(E=6e-58)
Swiss-Prot: Protease Do-
like 2 [Arabidopsis thaliana]
(E=2e-80)
Complete ER2
Subtilisin 1 ETH_00009790 on
Supercontig_570
SB S8 Cryptosporidium parvum Iowa
II chromosome 6 chr6.s2
(E=2e-22)
Swiss-Prot: Cell wall-
associated protease
[Bacillus subtilis] (E=8e-18)
Partial ER2
Subtilisin 2 ETH_00025145 on
Supercontig_1463
SB S8 Cryptosporidium muris RN66
gcontig_1106632353939
(E=8e-18)
Swiss-Prot: Major
intracellular serine
protease [Bacillus subtilis]
(E=4e-9)
Partial ER1/2
Subtilisin 3 ETH_00011050 on
Supercontig_4
SB S8 Cryptosporidium muris RN66
gcontig_1106632353939
(E=1e-39)
PDB: Subtilisin [Bacillus
licheniformis] (E=3e-28)
Complete ER2
Subtilisin 4 ETH_00006825 on
Supercontig_65
SB S8 Cryptosporidium parvum Iowa
II chromosome 6 chr6.s2
(E=3e-53)
PDB: Thermitase
[Thermoactinomyces
vulgaris] (E=3e-32)
Complete ER2
Subtilisin 5 ETH_00011340 on
Supercontig_4
SB S8 Toxoplasma gondii ME49
gcontig_1112359859078
(E=3e-24)
PDB: Thermostable Serine
Protease [Bacillus sp]
(E=8e-7)
Partial ER3/4
Subtilisin 6 ETH_00016890 on
Supercontig_22
SB S8 Toxoplasma gondii VEG
gcontig_1104442818966
(E=6e-34)
PDB: Thermitase
[Thermoactinomyces
vulgaris] (E= 4e-11)
Partial ER3/4
Prolyl endopeptidase ETH_00028960 on
Supercontig_1
SC S33 Neospora caninum Liverpool
complete genome,
chromosome V (E=2e-6)
Swiss-Prot: prolyl
endopeptidase [Mus
musculus] (E=4e-98)
Complete ER2
Clp protease ETH_00030480 on
Supercontig_126
SK S14 - Swissprot: ATP-
dependent Clp protease
proteolytic subunit
[Neisseria meningitidis]
(E= 3e-11)
Partial ER3/4
Rhomboid protease ETH_00020020 on
Supercontig_2
ST S54 Plasmodium falciparum Santa
Lucia cont1.4986, (E=1e-23)
Swiss-Prot: Rhomboid-like
protease 1 [Toxoplasma
gondii] (E=3e-47)
Complete ER1/2
The E. tenella genome database (www.genedb.org/Homepage/Etenella) was searched for genes predicted to code for proteins with peptidase activity. All auto-
annotated peptidase genes identified were manually curated by performing BLAST analysis against apicomplexan genome sequence databases and various
protein databases [32] such as the protein data bank (PDB), Swiss-Prot and non-redundant (NR). In addition, signature protein motifs for the protein sequence of
each gene were identified through Pfam (http://pfam.sanger.ac.uk/search; [33]), InterproScan (http://www.ebi.ac.uk/Tools/pfa/iprscan/) and the MEROPS databases
(http://merops.sanger.ac.uk/; [34]). Further gene sequence manipulations, such as translation into amino acid sequences and ClustalW alignments, were performed
using the DNASTAR Lasergene™ 9 Core Suite. Genes were assigned a five-tiered level of confidence for gene function using an Evidence Rating (ER) system
giving an overall score of ER1-5, where ER1 indicates extremely reliable experimental data to support function and ER5 indicates no evidence for gene function
[17].
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described previously [18]. The E. tenella β-actin gene was
amplified from each of the parasite lifecycle cDNA sam-
ples and quantification of bands visualized by agarose gel
electrophoresis allowed the specific E. tenella cDNA to be
standardized to each other accordingly. The E. tenella
gam56 gene product, which is predominantly expressed in
gametocytes but largely down-regulated in unsporulated
oocysts, confirmed the quality of gametocyte cDNA andserved as a gametocyte-specific positive control, establish-
ing the lack of gametocytes in merozoite and oocyst sam-
ples. The amplification of the tfp250 gene, specifically
expressed in the asexual stages [19], indicated contaminat-
ing merozoite cDNA in the gametocyte cDNA sample, as
anticipated, at the 134 h time point. Furthermore, amplifi-
cation of a chicken host-specific lysozyme gene indicated
host cDNA was present in both merozoite and gametocyte
preparations, also as anticipated.
Figure 1 RT-PCR assessment of purity of Eimeria tenella
merozoites, gametocytes and oocysts. Total RNA was extracted
from E. tenella merozoite (M), gametocyte (G), unsporulated oocyst
(UO) and sporulated oocyst (SO) preparations. cDNA was
synthesized and stage-specific parasite genes (GAM56 for
gametocytes; TFP250 for merozoites and sporozoites) was amplified
by RT-PCR. PCR samples were run alongside chicken host cDNA (H),
E. tenella genomic DNA (gD) and a negative control sample with no
template (−) on a 1% agarose gel. The E. tenella β-actin gene
product was used to standardize loading of parasite cDNA samples.
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samples, primer pairs were designed to generate PCR
products from exons of less than 1 kb in size, where
possible. PCRs were performed at optimal annealing
temperatures specific for the individual primer pairs and
annealing times optimal for predicted cDNA sized pro-
ducts. PCRs were performed at least twice (and normally
three times) for each gene product, by different
researchers each time. In the case of failed PCRs, primer
pairs were redesigned and retested. Results of PCR on
the different lifecycle stages of E. tenella indicated that
40 of the 45 protease genes could be amplified from
parasite cDNA (Table 2). The five PCRs that failed to
amplify a product from cDNA were for three of the
eight ubiquitinyl hydrolases, the single OTU protease
and one of the six subtilisins. However, it was possible
to amplify PCR products from gDNA for all five of these
proteases that, when sequenced, confirmed primer speci-
ficity (data not shown). The failure to amplify a product
from cDNA for these genes may be due to genome
annotation problems; possibly the sequence targeted by
our primers is not transcribed or falls in unpredicted in-
tronic regions. Alternatively, a low abundance of these
transcripts may have contributed to the failure to detect
cDNA amplification products. Further work will be
required to characterize these genes. All other PCR pro-
ducts from cDNA from the four E. tenella lifecycle
stages were directly sequenced to confirm the correct
coding sequence. Expected and actual cDNA amplicon
sizes and their corresponding sequence accession num-
bers are shown in Table 2.
The majority of the protease genes were expressed in
more than one of the four parasite stages investigated
(Table 2). However, stage-specific up- or downregulation
of protease gene expression was evident. Thus, taking
into account that merozoite cDNA contaminates thegametocyte samples, it is safe to conclude that there
were a large number (at least 15, probably 17) of prote-
ase genes whose expression was upregulated in mero-
zoites including eimepsin 3, cathepsin C1, calpain,
several of the ubiquitinyl hydrolases, an ATP-dependent
Zn protease, the CAAX prenyl protease, three of the five
insulysins, the leucyl aminopeptidase, the O-sialoglyco-
protease, one of the trypsins, a subtilisin, the Clp prote-
ase and rhomboid protease 1. Aminopeptidase N1
appeared to be downregulated specifically in merozoites.
Gametocyte-specific or gametocyte-upregulated pro-
teases were also common, with thirteen in all, also dis-
tributed across the four groups of proteases, including
eimepsin 2, cathepsin C2, ubiquitinyl hydrolase 2 and 5,
the pyroglutamyl peptidase, aminopeptidase N2, insuly-
sin 4, the S2P-like metalloprotease, two trypsin-like
proteases and three of the subtilisins. Additionally, two
other proteases were upregulated or specific for the
sexual phase of the lifecycle (i.e., gametocytes and
unsporulated oocysts), namely, cathepsin C3 and subtili-
sin 4. Cathepsin L appeared to be downregulated
specifically in gametocytes. Only two protease genes, a
pepsin-like protease with high homology to eimepsin
(eimepsin 1) and an insulysin, were switched on exclu-
sively in oocyst lifecycle stages. In contrast, numerous
protease genes appeared to be downregulated in sporu-
lated oocysts (Table 2).
Protease processing of GAM56
Gametocytes from E. tenella-infected caeca were lysed
and immediately incubated with or without protease
inhibitors for various lengths of time, and the native
GAM56 protein analysed by SDS-PAGE and western
blotting with anti-GAM56 antibodies, as described
previously [20,21], to track the disappearance of the pro-
tein to determine whether any inhibitors could prevent
the degradation observed in the presence of native gam-
etocyte proteases. The precise epitopes recognised by
the anti-GAM56 polyclonal antibodies are not known
for E. tenella though there is some evidence, from work
with E. maxima [21], that they are located in the con-
served amino-terminus of the protein. The anti-GAM56
antibodies are, thus, very useful for sensitive and specific
tracking of the degradation of GAM56. No disappear-
ance of GAM56 was apparent after 2, 4, 6, 8, 10, 12 or
16 h (data not shown) but was obvious at 24h (Figure 2).
The 24 h assay was therefore repeated three times with
a comprehensive range of protease inhibitors (Table 3)
targeting the four protease families identified in the gen-
ome. The aspartyl protease inhibitor, pepstatin A, had
no effect on GAM56 disappearance (Figure 2). None of
three cysteine protease inhibitors investigated,
Z-Phe-Ala-diazomethylketone (data not shown), N-
ethylmalemide (data not shown) or E64 (Figure 2)
Table 2 Expression of protease genes in merozoites, gametocytes, unsporulated oocysts and sporulated oocysts of
Eimeria tenella
Protease group cDNA product Stage specific expression Predicted
amplicon size
Actual
amplicon size
Genbank accession
number
Aspartic Proteases M G UO SO (bp) (bp)
Eimepsin 1 Oocyst Specific 357 659 AJ293829
Eimepsin 2 Gametocyte Specific 467 467 JX503496
Eimepsin 3 Merozoite Upregulated 578 578 JX503497
Cysteine proteases
Cathepsin B Downregulated in Sporulated Oocyst 656 656 JN641867.1
Cathepsin L Downregulated in Gametocytes 330 300 JX503498
Cathepsin C1 Merozoite Upregulated 547 547 JX503499
Cathepsin C2 Gametocyte Upregulated 273 273 JX503500
Cathepsin C3 Gametocyte and Unsporulated
Oocyst Upregulated
436 436 JX546580
Calpain Merozoite Upregulated 831 806 JX503501
Ubiquitinyl hydrolase
1
Merozoite Upregulated 548 548 JX503503
Ubiquitinyl hydrolase
2
Gametocyte Upregulated 395 395 JX503504
Ubiquitinyl hydrolase
3
Merozoite, possibly Gametocyte
Upregulated
698 698 JX503505
Ubiquitinyl hydrolase
4
Merozoite Upregulated 499 499 JX503506
Ubiquitinyl hydrolase
5
Gametocyte Upregulated 674 719 JX503507
Ubiquitinyl hydrolase
6
- 546 - -
Ubiquitinyl hydrolase
7
- 529 - -
Ubiquitinyl hydrolase
8
- 303 - -
OTU protease - 802 - -
Pyroglutamyl
peptidase
Gametocyte Upregulated 735 771 JX503502
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Table 2 Expression of protease genes in merozoites, gametocytes, unsporulated oocysts and sporulated oocysts of
Eimeria tenella (Continued)
Metalloproteases
Aminopeptidase N 1 Downregulated in Merozoite 602 602 JX503508
Aminopeptidase N 2 Gametocyte Upregulated 636 636 JX503509
ATP-dependant Zn
protease 1
Downregulated in Sporulated Oocyst 604 604 XM_001238661.1
ATP-dependant Zn
protease 2
Merozoite Upregulated 389 389 JX503516
ATP-dependant Zn
protease 3
Downregulated in Sporulated Oocyst 567 1045 JX503517
CAAX prenyl protease Merozoite Upregulated 368 368 JX503518
Insulysin 1 Merozoite Upregulated 294 294 JX503510
Insulysin 2 Merozoite Upregulated 416 416 JX503511
Insulysin 3 Oocyst Specific 402 697 JX503512
Insulysin 4 Gametocyte Upregulated 367 367 JX503513
Insulysin 5 Merozoite Upregulated 202 202 *
Leucyl
aminopeptidase
Merozoite, possibly Gametocyte
Upregulated
804 859 JX503514
O-sialoglycoprotease Merozoite Upregulated 412 412 JX503515
S2P-like protease Gametocyte Specific 616 1027 JX503519
Serine proteases
Trypsin 1 Gametocyte Specific 613 613 JX503520
Trypsin 2 Gametocyte Upregulated 721 721 JX503521
Trypsin 3 Merozoite Upregulated 654 849 JN987371.1
Subtilisin 1 Gametocyte Specific 260 260 XM_001238722.1
Subtilisin 2 Gametocyte Specific 690 690 XM_001238654.1
Subtilisin 3 Merozoite Upregulated 1171 1084 JX503522
Subtilisin 4 Gametocyte and Unsporulated
Oocyst Upregulated
566 566 JX503523
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Table 2 Expression of protease genes in merozoites, gametocytes, unsporulated oocysts and sporulated oocysts of
Eimeria tenella (Continued)
Subtilisin 5 Gametocyte Specific 360 414 JX503524
Subtilisin 6 - 365 - -
Prolyl endopeptidase Downregulated in Sporulated Oocyst 534 534 JX503526
Clp protease Merozoite Upregulated 413 241 JX503525
Rhomboid protease 1 Merozoite Upregulated 554 554 JN987619.1
M Merozoites, G Gametocytes, UO Unsporulated Oocysts, SO Sporulated Oocysts.
* = short sequence not accepted for submission.
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protease inhibitor, chymostatin (data not shown) and
leupeptin (Figure 2), inhibited GAM56 disappearance
but another inhibitor with the same specificity, antipain,
did not (data not shown). The serine protease specific
inhibitors, benzamidine HCL (data not shown), soybean
trypsin inhibitor (data not shown) and aprotinin
(Figure 2) all inhibited the disappearance of GAM56 but
AEBSF did not (Figure 2). The metal chelating agent,
EDTA, also inhibited the disappearance of GAM56 but
more specific metalloprotease inhibitors, bestatin and
phosphoramidon, did not (Figure 2).Figure 2 The effect of protease inhibitors on degradation of
GAM56 in Eimeria tenella gametocytes. A sample of purified E.
tenella gametocytes was lysed and equal volumes of lysate added to
a range of protease inhibitors (see Table 3 for details on
concentrations and specificity) or PBS. A zero time point sample was
taken immediately. Other samples were incubated for 24 h at 37°C,
after which the assay was halted by addition to Laemmli buffer and
the samples subjected to SDS-PAGE and immunoblotting as
described previously [20,21] to assess the disappearance of GAM56.
Lane 1, time = zero sample; Lane 2, pepstatin A; Lane 3, E64; Lane 4,
aprotonin; Lane 5, AEBSF; Lane 6, bestatin; Lane 7, leupeptin; Lane 8,
phosphoramidon; Lane 9, EDTA; Lane 10, a cocktail of pepstatin A,
E64, aprotonin, AEBSF, bestatin, leupeptin, phosphoramidon and
EDTA; Lane 11, control sample containing no protease inhibitors.Discussion
Mining of the E. tenella genome database has revealed
over 40 protease transcripts distributed over 13 clans
and 18 families of aspartic, cysteine, metallo and serine
proteases. Such diversity of proteases is not unusual, in-
deed it may be an underestimate of the true number of
protease genes in this parasite since other apicomplexan
parasites are known to possess substantially more prote-
ase genes (Table 4); thus, for example, there are at least
70 in Cryposporidium parvum, more than 80 in P.
falciparum and over 90 in T. gondii, though other api-
complexan parasites possess similar numbers of protease
genes as E. tenella. Eimeria tenella also has lower num-
bers of protease genes than protozoan parasites like
Leishmania, Trypanosoma and Trichomonas (though the
latter is known to have an unusually expanded genome
in general [22] and, apparently, in C1 and C19 cysteine
proteases and M8 metalloproteases, in particular;
Table 4). But, again, E. tenella has a broadly similar total
number of protease genes to Entamoeba dispar and
Giardia intestinalis, which are also intestinal parasites.
However, the fact that our dataset for E. tenella lacks
protease genes for several families, across all four types
of proteases, that are represented in all other Apicom-
plexa and most other protozoan parasites, including
A28, A22, C12, C85, C86, C13, C14, C50, C48, M24,
M18, M67, S9, S26 and S16, provides reason to believe
that some E. tenella protease genes remain unannotated.
The apparent stage-specific regulation of protease
genes in E. tenella is striking and intriguing. Most inves-
tigations of parasitic protozoan proteases have focused
on the asexual stages of the apicomplexan parasites, T.
gondii and P. falciparum, establishing crucial roles for
proteases in host cell invasion, remodelling and egress
by the asexual stages of these parasites [1]. Our finding
that expression of up to 17 of 40 protease genes
Table 3 Protease inhibitors used in the Eimeria tenella
GAM56 processing assay
Inhibitor Inhibitor
target
Final
concentration
Company
Pepstatin A Aspartyl 1 μm Sigma-
Aldrich
N-ethylmalemide Cysteine 1 mM Sigma-
Aldrich
E-64 Cysteine 10 μM MP
Biomedicals
Z-Phe-Ala-
diazomethylketone
Cysteine 2 μM Bachem, UK
Antipain Ser + Cys 100 μM MP
Biomedicals
Chymostatin Ser + Cys 200 μg/ml Sigma-
Aldrich
Leupeptin Ser + Cys 100 μM Sigma-
Aldrich
AEBSF Serine 1 mM Sigma-
Aldrich
Aprotinin Serine 0.002 TIU MP
Biomedicals
Benzamidine HCl Serine 4 mM Sigma-
Aldrich
Soybean Trypsin
inhibitor
Serine 100 μg/ml Sigma-
Aldrich
Bestatin Metallo
(amino)
40 μM Sigma-
Aldrich
Phosphoramidon Metallo
(endo)
10 μM MP
Biomedicals
EDTA di-sodium salt Metallo 5 mM Sigma-
Aldrich
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ther underscores the importance of proteases in the biol-
ogy of the asexual stages of apicomplexan parasites. Not
surprisingly, therefore, an eimepsin, several cathepsins, a
calpain, a trypsin-like protease, subtilisins, Clp and a
rhomboid protease are upregulated in the asexual stages
of E. tenella (Table 2). Likewise, eimepsin1 and insulysin
3 are expressed specifically in oocysts and may play an
important role in the first steps of the parasite lifecycle,
such as host cell invasion; they are, therefore, worthy of
further research. The downregulation of several pro-
teases (including cathepsin B, ATP-depenedent ZN
proteases 1 and 3, and a prolyl endopeptidase) in sporu-
lated oocysts may be, in part, attributed to the dormancy
of this lifecycle stage, yet still warrants further
investigation.
Perhaps the most significant finding of our stage-
specific expression study was the relatively large number
of protease genes whose expression is upregulated spe-
cifically in the gametocytes stage – a total of at least 13
genes, including six that are only expressed in gameto-
cyte (Table 2). This observation becomes even more
intriguing when examined in the context of thedistribution of different families of proteases across para-
sitic protozoa (Table 4). Four classes of proteases stand
out amongst the protozoa because they are only found,
or are “over-represented” in the two Coccidian parasites,
E. tenella and T. gondii – families C15, M50, S1 and S8.
Eimeria tenella contains a total of eleven protease genes
distributed unevenly across these families, with only one
in C15 and M50 and three and six in the serine protease
families, S1 and S8, respectively. But, even more signifi-
cantly, all but three of these unique protease genes are
upregulated or confined in expression to the gametocyte
stage of the parasite. Thus, expression of a pyroglutamyl
peptidase, a trypsin-like protease and subtilisin 4 is upre-
gulated in gametocytes whilst expression of an SP2-like
protease, a trypsin 1-like protease and three subtilisins is
entirely gametocyte specific.
One of the defining features of the Coccidia is the
possession of a hard-walled oocyst that originates from
specialized organelles (wall forming bodies) in macroga-
metocytes. It is hypothesized [16] that degradation of
two proteins found in the wall forming bodies of macro-
gametocytes of Eimeria, namely GAM56 and GAM82, is
integral to oocyst wall formation; tyrosine-rich peptides
formed by the degradation of these two proteins are
believed to be subsequently cross-linked via dityrosine
bonds [23], giving the oocyst wall its renowned strength
and resistance to environmental and chemical insults
[24]. To test this hypothesis, we designed an assay to fol-
low the degradation of GAM56 in freshly harvested
gametocytes (Figure 2). This assay has certain inherent
limitations: first, it relies on sensitive antibodies for de-
tection of specific degradation of GAM56 and, unfortu-
nately, the lack of suitable antibodies for detection of
GAM82 in E. tenella [21] meant that we were unable to
run confirmatory experiments with this protein; and,
second, the only controls possible are a zero time point
and a cocktail of protease inhibitors designed to prevent
all proteolytic activity. These limitations require us to be
cautious in our interpretations; none-the-less, the inhib-
ition of degradation of native GAM56 by a very specific
group of protease inhibitors reveals that this function
may be carried out by subtilisin-like proteases. Thus,
degradation of GAM56 was inhibited by the serine/cyst-
eine protease inhibitors, chymostatin and leupeptin, and
the serine protease specific inhibitors, benzamidine HCL,
soybean trypsin inhibitor and aprotinin but not by AEBSF
(Figure 2). Intriguingly, the metal chelating agent, EDTA,
also inhibited degradation of GAM56. This profile indicates
that serine proteases are critical for degradation of GAM56
but it seems to rule out participation of rhomboid pro-
teases, which are unaffected by EDTA, aprotonin, leupeptin
and chymostatin [25]. Trypsin-like proteases can, perhaps,
not be completely ruled out of this process but the inhibi-
tory profile, particularly the lack of inhibition by AEBSF
Table 4 Distribution of protease clans and families in Eimeria tenella, its host and other protozoan parasites
Clan Family G.g E.t T.g C.p C.h C.m P.f P.v P.b P.c P.y T.a T.p E.d L.b L.i L.m T.b T.c T.v G.i
AA A1 11 3 8 4 3 6 11 6 5 3 9 4 3 1
A2 3
A28 1 1 2 1 1 1 1 1 1 2 1 1 1 1 1 1 1 2 6
AD A22 6 1 1 1 1 1 1 1 1 4 2 2 2 2 2 4 2
CA C1 12 5 4 5 4 4 10 9 8 4 8 12 10 15 3 4 3 2 7 42 21
C2 12 1 2 1 1 2 1 2 2 1 1 1 2 2 2 1 2 4
C12 4 2 2 2 1 2 1 2 2 2 1 2 2 2 1
C19 30 8 1 7 3 2 7 1 2 3 4 5 1 1 3 1 9 8 3 68 4
C51 1 1 2 3 2
C54 3 1 1 1 4 2 2 2 2 2 5
C64 4
C65 1 1 1 1 1 1
C66 1
C67 2
C78 1 1 1 1 1 1 1 1 1 1 1
C85 2 1 1 1 2 1 1 1
C86 2 1 1 1 1 1 1 1 1
C88 1 1 1 1 1 1 1 1 1 1
CD C11 1 1 1
C13 2 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 9 2
C14 12 2 1 1 1 1 1 1 1 1 1 2 2 6
C50 1 1 1 1 1 1 1 1 1 1 1
CE C48 6 3 2 1 1 1 1 1 2 2 2 2 1 1 1 6
CF C15 2 1 1 1 1 1
CO C40 6
M- M49 1 1 1 1 1 2
M76 1 3 1 1 1 1 1 1 1 1 1 2
M79 1 1 1 1 1 2 1 1
MA M1 10 2 3 1 1 1 1 1 1 1 1 1 1 2 2 4 2 3 3
M2 3
M3 3 3 2 2 2 2 3 1 2 3 3 4 2 3 1
M8 1 1 24 8 4 9 76 42
M10 16
M12 35
M13 8 1
M32 2 3 4 1 2
M41 1 3 3 1 1 3 3 3 3 4 3 3 1 5 5 5 5 1
M43 2
M48 1 1 1 1 1 1 1 1 1 1 1 1 1 1 4
M54 1 1 1 1
M80 1 1 1 1 1 1 1 1
MC M14 14 1 1 1 1 2 2 3 3 3 4
ME M16 12 5 7 8 4 4 4 3 4 1 4 5 4 2 2 3 3 3 3 7 3
MF M17 3 1 1 1 1 1 1 1 1 3 2 1 1 3 3 3 3 3
MG M24 6 3 2 3 2 5 4 4 3 5 4 4 3 3 3 4 4 4 8 3
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Table 4 Distribution of protease clans and families in Eimeria tenella, its host and other protozoan parasites (Continued)
MH M18 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 5
M20 4 1 1 6 3 4 7 4 8 10 3
M28 10 1 1
MJ M19 1
M38 4
MK M22 2 1 1 1 1 1 2 1 1 1 2 2 1 1 1 1 1 1 1 1 2
MM M50 1 1 1
MP M67 7 2 2 2 1 1 1 1 1 1 2 2 2 2 2 3 1 3 4 2
PA S1 66 3 4 1 2 1
SB S8 10 6 11 1 1 3 3 2 2 2 1 2 2 11
SC S9 15 4 10 3 2 3 1 1 2 2 1 2 5 4 7 8 8 8 5
S10 2 1 1 1 3 1
S15 1 1 1 1 1
S28 1 1 2 1 8 2
S33 3 1 2 3 1 6 1 1 4 1 1 2 1 2 1 2 13 7
SE S12 1
SF S26 4 1 1 1 1 1 1 1 2 2 1 2 2 2 2 1 3
SJ S16 2 1 1 1 1 1 1 1 1
SK S14 1 1 1 1 1 1 2 1
S41 1
SP S59 1 1 1 1
SR S60 1
ST S54 6 1 6 3 2 3 7 2 4 2 5 1 1 1 2
Clan Family G.g E.t T.g C.p C.h C.m P.f P.v P.b P.c P.y T.a T.p E.d L.b L.i L.m T.b T.c T.v G.i
The distribution of families within clans of aspartic (AA, AD), cysteine (CA, CD, CE, CF, CO), metallo (M-, MA, MC, ME, MF, MG, MH, MJ, MK, MM, MP) and serine (PA,
SB, SC, SE, SF, SJ, SK, SP, SR, ST) proteases of Eimeria tenella is compared with its host (Gallus gallus, the chicken) and other protozoan parasites from the MEROPs
database of peptidases in whole genome sequences (merops.sanger.ac.uk/cgi-bin/compgen_index?type=P; [34]). Sequences for non-peptidase homologs are not
included in the table. G.g = Gallus gallus; E.t = Eimeria tenella; T.g = Toxoplasma gondii; C.P. = Cryptosporidium parvum; C.h = Cryptosporidium hominis; C.m =
Cryptosporidium muris; P.f = Plasmodium falciparum; P.v = Plasmodium vivax; P.b = Plasmodium berghei; P.c = Plasmodium chabaudi; P.y = Plasmodium yoelii; T.a =
Theileria parva; P.a = Theileria annulata; E.d = Entamoeba dispar; L.b = Leishmania braziliensis; L.i = Leishmania infantum; L.m = Leishmania major; T. b =
Trypanosoma brucei; T.c = Trypanosoma cruzi; T. v = Trichomona vaginalis; G.i = Giardia intestinalis.
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tilisin or subtilisins as P. falciparum subtilisin 1 is inhibited
in exactly the same fashion [26].
Subtilisins are further implicated in the formation of the
oocyst wall of Eimeria through analogy with their known
role in the formation of the cuticle of nematodes. Thus, the
assembly of collagens to form the cuticle involves a number
of molecular events that strikingly resemble our model of
oocyst wall formation pathways: first, collagens are the re-
sult of degradation of proproteins by a subtilisin-like prote-
ase [27-30]; and, second, these collagens are subsequently
bonded together by di- and tri-tyrosine crosslinks [31]. A
failure in either of these steps, results in a malformed cu-
ticle and parasite death [31]. Subtilisins are currently being
further investigated as potential candidates in the catalytic
cleavage of the oocyst wall precursor proteins.
Conclusion
Eimeria tenella possesses a large number of genes coding
for proteolytic enzymes, which display a remarkable patternof stage specific expression. As in other apicomplexan para-
sites such as P. falciparum and T. gondii, expression of
many of these genes is upregulated in the asexual, invasive
stages, possibly indicating important roles in host cell inva-
sion, remodelling and egress. However, expression of al-
most one-third of the protease genes identified in the E.
tenella genome is upregulated or confined to the sexual
gametocyte stage of this parasite’s lifecycle; some of these
appear to be unique to Coccidia and may play key roles in
the formation of the resilient oocyst wall, a defining feature
of this group of important parasites.
Methods
Data-base mining
Eimeria tenella genome sequences and gene models were
downloaded from GeneDB (http://www.genedb.org/Home
page/Etenella). The genome of E. tenella (Houghton strain)
was produced by the Parasite Genomics Group at the Well-
come Trust Sanger Institute (http://www.sanger.ac.uk/re-
search/projects/parasitegenomics/) and has been provided
Table 5 Primers for Eimeria tenella protease genes for the amplified coding sequences
Protease gene Primer Primer sequence 50 to 30
Aspartic Proteases
Eimepsin 1 F ATC ACC ACA CCA CCA TGG G
R CAA GAT TCG AGC AGT TCT CAG CA
Eimepsin 2 F AGC AAA CAG CTG CAG ATG TTC C
R CGA AAA TAG GTC TAG GGG CCC
Eimepsin 3 F AGA AGT CCT TTC CTC CGT CAC G
R GGC GAA GTG TAT TGA AAG CTC G
Cysteine Proteases
Cathepsin B F TGA CGT GGG AAG CAG AAG TGT C
R ACT GTA TGC ACT CGT GGC GAA A
Cathepsin L F CAA CCA ACA AGG TCA CTC TTA C
R CCC TGG AGG GCC CCC GTG CTC G
Cathepsin C1 F AAC GGA AGT GGA GAA GAC AGC A
R CGG GGT CAA TGA AGG AAG TTT G
Cathepsin C2 F GGC TTT GAA GTT TGG CAG CG
R TGC ATC TGA GCA GCA GAA GAG
Cathepsin C3 F CGC TCA GGA GTA CAA CTA CGT GGG TGG
R GCT GCT GCA CAA GCA GCG CTG CTC TGC C
Calpain F CGA CTG CTC CTT CCT CTC
R GCA TCC TTT AGC TGC TGG
Ubiquitinyl hydrolase 1 F CTG GCT CTT GAA TGT GCT GCA T
R CTT CCA TTT CGT GCC ATT CG
Ubiquitinyl hydrolase 2 F TTG GAC TTC AGC CCG AGG AG
R CCG CTC GTC AAA TCC CAA AG
Ubiquitinyl hydrolase 3 F AGG TGG TGC CCC TCG ACA TA
R TTC TGC TGC CGT GCT CTT TG
Ubiquitinyl hydrolase 4 F GTG AAT GTG GGC AGC ACC AG
R GCT TTC CTG CAA GGC GAA GA
Ubiquitinyl hydrolase 5 F TCT CTT CCA GGG GCA GTA CAG G
R GCT GCT CGT AGG CCA TAT TTG AAC
Ubiquitinyl hydrolase 6 F GGT GGC CAG CAT AGA CGA GAG T
R CCG TAG GTT TGC TGC GAT CTC T
Ubiquitinyl hydrolase 7 F CGA CAG TCC CGT TGT TGC TG
R AGC AAG CCG GGG AAA GAG AC
Ubiquitinyl hydrolase 8 F TCC TGG AGG CCT TGA GCA GT
R TGC TGC TCA CTG GGA TGT GG
OTU protease F ATG GAC GTA GCA ATC CGT TAC
R GTT GCT GCA CAT AGT CCC AAG
Pyroglutamyl peptidase F ATG GGA CAA CCT ACA GGC GAG
R GAG GAA GTT ACA AAC GAA GCA GC
Metallo Proteases
Aminopeptidase N 1 F CAA GCA GTA CAC TCC AGC AAC TC
R GAA GCG TCA GGT GTT CGT ATT CC
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Table 5 Primers for Eimeria tenella protease genes for the amplified coding sequences (Continued)
Aminopeptidase N 2 F GAT ACA TCG CAA GGA CTA CAG C
R CAT TGT GCG GAA GGA GTC TG
ATP-dependant Zn protease 1 F CTT CGA CCA GCT GAA GAT CCT G
R TGT CTC CGC GCT AAT GCT G
ATP-dependant Zn protease 2 F CTC AAT GGT GGA TTT CAG CAA G
R CAT CAT TCC CTG GCT TGC G
ATP-dependant Zn protease 3 F GTC AAG AAA GCA GAT TGT CAG G
R CTC GAC AGC CAT CTC AAA GTC
CAAX prenyl protease F GAA TGT CCC AGG AGA GCT ATG C
R GTT CAC AGC GCA CAG AAT TGG
Insulysin 1 F CAC TTC CTG GAG CAC ATG G
R GTG CAG CCT GTC GAA GAT G
Insulysin 2 F CCG CGG TAG CCT CTCA GC
R CTC CGC TGT TGC TCA CAT CTT C
Insulysin 3 F GAT TGA CGC CGA GCA CCA G
R GCT AGG CGA GCT GCT TCA TCC
Insulysin 4 F GTC GTG CAG AGA GGC TGG
R GAG GTA GCT GAG TCG GAG GG
Insulysin 5 F ATG ATA TTT CTG AAG TCT GC
R GAG GAT TCA AAA GAT GGT C
Leucine aminopeptidase F CAA GAT CTA GTT GTT TGA GGA GCC C
R GCT GTT CCA CTT CAC TCG TCT TC
O-sialoglycoprotease F GCA AAT GTG ACG CAG CTG ATT CG
R CGA ACT TGA GGG CCA TTT GCT C
S2P-like protease F GCC CTC GTA TAA CAG CAA C
R GAA CGA CTA ACT TCC TCT TGC
Serine Proteases
Trypsin 1 F GTA GGC AAC GGA ACT CCA GC
R CGA GGA CTA CAA CTG TCT CC
Trypsin 2 F ATG GAA GCG TCT GGT TGG GAC
R GCT TTT GCT GCA TGC ACT C
Trypsin 3 F GAC AAA CAA GTT CAA CGA GCA CTG
R GCT TCC CTC TCC GCA GAA TTG
Subtilisin 1 F TAA TTA CCT CCA TCC CGA ACT G
R CCA GAA TCT TCA GCG CCA TCA C
Subtilisin 2 F GCA GCA GCA AAT GTT GAA GAC CC
R ATA AGT GCT GCT GCC AAC CAC C
Subtilisin 3 F AGA GCT TTT GTC CGT GGT GGA G
R AAA GAC CCC GAA AAC CAA TGC T
Subtilisin 4 F CCT TTG TGG CGT GTT CGT GAG
R CCA GCA GAA GCA GTA CCG TGG CC
Subtilisin 5 F TTG AAG CCG ACA GGA CGT GG
R CCG CGT AGT CAA GAG CAG GGA T
Subtilisin 6 F AGC GGC TGC GAC TTG AAC C
R CCG TAG CCG CCG TAG GAG TT
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Table 5 Primers for Eimeria tenella protease genes for the amplified coding sequences (Continued)
Prolyl endopeptidase F ACA GCC AGG CAC ATC AAT GGT
R GCC AAA CCC AAG CCC AGA TAG
Clp protease F GCT GCA CTT CCA GAA GCG G
R CCT CCG CAG AGA AGA CTT TGC
Rhomboid protease 1 F GGT TGT CCG CAC GTT GGC AG
R CGA AGA TAA CAG GCA CGC AAG ATG
Katrib et al. BMC Genomics 2012, 13:685 Page 15 of 18
http://www.biomedcentral.com/1471-2164/13/685prepublication. The E. tenella genome database was searched
for genes predicted to code for proteins with peptidase ac-
tivity. All auto-annotated peptidase genes identified were
manually curated by performing BLAST analysis against
apicomplexan genome sequence databases and against vari-
ous protein databases [32] such as the protein data bank
(PDB), Swiss-Prot and non-redundant (NR) protein se-
quence databases. In addition, signature protein motifs for
the protein sequence of each gene were identified through
Pfam (http://pfam.sanger.ac.uk/search; [33]), InterproScan
(http://www.ebi.ac.uk/Tools/pfa/iprscan/) and the MER-
OPS databases (http://merops.sanger.ac.uk/; [34]). Further
gene sequence manipulations, such as translation into
amino acid sequences and ClustalW alignments, were per-
formed using the DNASTAR Lasergene™ 9 Core Suite.
After the bioinformatic information was collated, genes
were assigned a five-tiered level of confidence for gene
function using an Evidence Rating (ER) system giving an
overall score of ER1-5, where ER1 indicates extremely reli-
able experimental data to support function and ER5 indi-
cates no evidence for gene function [17].
Animals and parasites
One day old chicks (Australorp; Barter and Sons Hatchery,
Luddenham, Australia) were housed at the Ernst Facility
Animal House (University of Technology, Sydney), under
heat lamps for the first 2 weeks of their life and, thereafter,
at 21°C with a 12 hour light/dark cycle with free access to
food and water. Chickens were infected orally at 4.5 weeks
of age with 2.5 × 103 sporulated oocysts of Eimeria tenella
(Houghton strain originally provided by Janene Bumstead,
Institute for Animal Health, Compton, UK). Fresh E. tenella
oocysts were harvested 7 days post infection from the caeca
following protocols published previously [35]. Sporulation
of oocysts was carried out at 28°C for 72–120 hours using a
low-pressure aquarium pump to aerate the suspension.
Sporulated oocysts were then treated with 2.8 M NaCl and
2% sodium hypochlorite (Milton solution) and stored in 2%
potassium dichromate at 4°C until required. Unsporulated
oocysts were also treated with Milton solution and stored at
−80°C. Merozoites (112 h p.i.) and gametocytes (134 h p.i.)
were isolated from infected chicken caecae following tech-
niques published previously [36,37]. Aliquots of parasites
were either frozen at −80°C as pellets or were stored inTRIzolW reagent (Invitrogen) at −80°C for further use in
RNA purification.
RNA purification, cDNA synthesis and cDNA
standardisation
To isolate total RNA, purified merozoites (1 × 107)
and gametocytes (1 × 106) were resuspended in 1 ml
TRIzolW Reagent and homogenized by pipetting.
Unsporulated oocysts (2 × 105) and sporulated oocysts
(5 × 105) were resuspended in 1 ml TRIzolW Reagent
and one volume of glass beads were added to the sam-
ple, which were then vortexed for 1 min intervals until
disruption of oocyst was confirmed by bright field mi-
croscopy. All TRIzolW treated samples were left at room
temperature for 10 min and total RNA isolated by
chloroform extraction and isopropanol precipitation.
RNA was quantified using a NanoDrop™ ND-1000
Spectrophotometer and cDNA was synthesized using
SuperScript™ III Reverse Transcriptase (Invitrogen)
according to manufacturer’s instructions.
Parasite cDNA samples were standardized by relative
quantification of an E. tenella β-actin PCR product.
β-actin forward primer E0043 (50 ggaattcgttggccgcccaa
gaatcc 30) and reverse primer E0044 (50 gctctaga
ttagctcggcccagactcatc 30) were used to generate the
1020 bp β-actin cDNA PCR product. Each PCR reaction
contained 50 ng of parasite stage specific cDNA, 0.2 μM
forward primer, 0.2 μM reverse primer, 1 × AccuPrime™
reaction mix, and AccuPrime™ Pfx DNA polymerase
(Invitrogen). The PCR reaction was carried out as follows:
initial denaturation 95°C for 3 min; 95°C for 30 s; 61°C for
1 min; 68°C for 1.5 min, for 25 cycles with a final extension
at 68°C for 10 min. All products were electrophoresed on a
1% agarose gel and visualized using Gel Red™ (Biotium).
The net intensity of each band was determined using the
Kodak EDAS 290 Electrophoresis Documentation and
Analysis System and serial dilutions performed until rela-
tive intensity of PCR products were equal.
In addition, three control genes were amplified to de-
termine the purity of parasite lifecycle stages. The
GAM56 gene was used as a gametocyte specific gene.
GAM56 forward primer E0030 (50 catatggtggagaa
cacggtgcac 30) and reverse primer E0031 (50 ctcgagttagt
accagctggaggagta 30) were designed to amplify a 906 bp
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of 61°C. The EtTFP250 gene, a homolog of an E.
maxima gene encoding a microneme protein, was used
as an asexual stage control. The EtTFP250 forward pri-
mer Et250F (50 gcaaggacgttgacgagtgtg 30) and Et250RV1
(50 gttctctccgcaatcgtcagc 30) were designed to amplify an
805 bp cDNA product, at an annealing temperature of
60°C. The chicken lysozyme gene was used to determine
relative quantities of contaminating host cDNA. The for-
ward primer RW3F (50 acaaagggaaaacgttcacgattggc 30)
and reverse primer RW4R (50 tgcgttgttcacaccctgcatatgcc
30) were designed to amplify a 280 bp host cDNA prod-
uct at an annealing temperature of 60°C.
Semi-quantitative PCR
The predicted coding regions of each protease gene were
examined for potential primer sites within 1 kb of each
other where possible. Primers were designed as detailed in
Table 5.
PCRs were conducted on cDNA samples from E. tenella
merozoites, gametocytes, unsporulated and sporulated
oocysts. PCR were optimized to produce cDNA sized pro-
ducts. Negative controls of no DNA template and host
cDNA were run alongside a positive genomic DNA control.
When genomic DNA products were not amplified, a repeat
PCR was performed at longer annealing times to produce
the often much larger genomic DNA product. A typical
PCR was as follows: 1μL of standardized cDNA sample,
0.2 μM forward primer, 0.2 μM reverse primer, 1 × Accu-
Prime™ reaction mix, and AccuPrime™ Pfx DNA poly-
merase (Invitrogen). Cycling conditions typically involved
an initial denaturation at 95°C for 3 min, followed by 25
cycles of denaturation 95°C for 30 s; annealing at Tm-5 for
1 min; extension at 68°C for 1.5 min. When products were
to be sequenced, a final extension at 68°C for 10 min was
performed at the end of the PCR reaction. PCRs were per-
formed at least twice and, generally, three times for each
gene product by a different researcher each time.
All amplified products were gel purified using a
QIAquickW Gel Extraction Kit (QIAGEN) according to the
manufacturer’s instructions and sequenced (Australian
Genome Research Facility, Queensland). When cDNA pro-
ducts were amplified from different parasite stages, these
were pooled and used in sequencing reactions. When
cDNA products were not obtained, additional primers were
designed and used. If a cDNA product was still unable to
be amplified with the second primer pair, genomic DNA
products were sequenced to confirm primer specificity.
Sequences were analysed using DNASTAR Lasergene™ 9
Core suite.
GAM56 processing assay
A frozen sample of purified E. tenella gametocytes (1 ×
106 cells in 100 μL) was resuspended in PBS (145 mMNaCl, 7.5 mM Na2HPO4, 2.5 mM NaH2PO4.2H2O, pH
7.4) to a final volume of 500 μL. Glass beads (250 μL of
710-1180 μm, Sigma) were added to the suspension and
vortexed at full speed for three 1 min pulses with a 1
min pause on ice between each pulse. After three vortex
cycles, the sample was centrifuged and the lysate trans-
ferred to a clean tube. Equal aliquots of the gametocyte
extract (18 μL) were immediately added to either 2 μL of
10× protease inhibitor (Table 3) or PBS. A zero time
sample was taken from the PBS control and immediately
added to Laemmli sample buffer [38] and frozen. The
assay tubes were incubated at 37°C for 2, 4, 6, 8, 10, 12,
16 or 24 h, after which Laemmli sample buffer was
added and samples stored at −20°C for further
assessment.
SDS-PAGE and immunoblotting were carried out as
described previously [20,21]. Briefly, gametocyte assay
samples, resuspended in Laemmli sample buffer (5 μL),
were boiled for 5 min at 100°C prior to SDS-PAGE on a
NuPAGEW Novex 4-12% Bis-Tris Gel (Invitrogen).
SeeBlueW Plus2 Pre-Stained Standards (Invitrogen) were
used as a marker. Proteins separated by SDS-PAGE were
transferred electrophoretically (100 V, 1 hour, 4°C) to
Immobilon-P membrane (Millipore) in transfer buffer
(25 mM Tris–HCl, 192 mM glycine, 10% methanol).
Membranes were rinsed in methanol and water then
soaked for 10 min in transfer buffer prior to transfer.
Gels were pre-soaked for 15 min in transfer buffer. After
transfer, membranes were incubated overnight in block-
ing solution (5% w/v skim milk powder in PBS) at 4°C
and then incubated with primary antibody (1:1000 rabbit
anti-EmGAM56) for 2 h at room temperature. Each
membrane was washed twice for 5 min and twice for 10
min in 0.05% Tween 20 in PBS then incubated with sec-
ondary antibody (1:1000 anti-rabbit IgG conjugated to
alkaline phosphatase; Sigma) for 2 h at RT. Membranes
were washed as above and bands visualized with SIGMA
FAST™ BCIP/NBT buffered substrate (Sigma).
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